We are live on ! Find out more
RPC

Rossmore Private Capital Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.92%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+28.92%
3 Year Est. Return
+75.43%
5 Year Est. Return
+104.51%
10 Year Est. Return
–
AUM
$764M
AUM Growth
+$56.6M
Cap. Flow
+$699K
Cap. Flow %
0.09%
Top 10 Hldgs %
37.83%
Holding
236
New
4
Increased
83
Reduced
70
Closed
3

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.96M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.5M
3
LLY icon
Eli Lilly
LLY
+$964K
4
NEE icon
NextEra Energy
NEE
+$294K
5
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$271K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.87M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.19M
3
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$871K
4
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$631K
5
AVGO icon
Broadcom
AVGO
+$607K

Sector Composition

Rank Sector Weight
1 Technology 16.07%
2 Energy 13.59%
3 Healthcare 12.08%
4 Financials 9.75%
5 Industrials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RWR icon
226
State Street SPDR Dow Jones REIT ETF
RWR
$1.97B
$212K 0.03%
2,245
– –
FLR icon
227
Fluor
FLR
$7.93B
$211K 0.03%
+5,000
New +$192K
ARKK icon
228
ARK Innovation ETF
ARKK
$6.29B
$209K 0.03%
+4,172
New +$203K
WBS icon
229
Webster Financial
WBS
$12.8B
$203K 0.03%
4,006
– –
SLRC icon
230
SLR Investment Corp
SLRC
$714M
$154K 0.02%
10,000
– –
GSAT icon
231
Globalstar
GSAT
$10.7B
$54.2K 0.01%
2,460
– –
MIN
232
Aberdeen Intermediate Income Fund
MIN
$278M
$27.3K ﹤0.01%
10,275
– –
MTNB icon
233
Matinas BioPharma
MTNB
$1.67M
$4.74K ﹤0.01%
350
– –
ARVN icon
234
Arvinas
ARVN
$566M
– –
-14,322
Closed -$589K
CMA
235
DELISTED
Comerica
CMA
– –
-4,000
Closed -$223K
SNOW icon
236
Snowflake
SNOW
$114B
– –
-1,046
Closed -$208K
6 7 8 9
10

Similar funds

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
HTHT
Hemenway Trust Hemenway Trust Salem, New Hampshire $1.24B AUM 16.52% 1-Year Est. Return
BCP
BlackBarn Capital Partners New York $1.24B AUM 55.98% 1-Year Est. Return
SPC
Stony Point Capital New York $1.24B AUM 32.69% 1-Year Est. Return

Rossmore Private Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Rossmore Private Capital held 236 positions worth $764M, up 8% from $708M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3%. Rossmore Private Capital opened 4 new positions and exited 3, leaving the 236-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Energy and Healthcare.

  • Rossmore Private Capital's largest Q1 2024 buy was AstraZeneca: 22,330 shares worth $3.03M.
  • Rossmore Private Capital added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $1.5M increase.
  • Rossmore Private Capital's biggest Q1 2024 reduction was Apple, cutting an estimated $1.87M.
  • Rossmore Private Capital fully exited Arvinas in Q1 2024, selling an estimated $589K.
  • Rossmore Private Capital's ten largest holdings make up 38% of its $764M portfolio in Q1 2024.
  • Rossmore Private Capital opened 4 new positions and closed 3 in Q1 2024.
  • Rossmore Private Capital's portfolio value rose 8% quarter-over-quarter to $764M.

Based on Rossmore Private Capital's 13F filing for Q1 2024, filed 13 May 2024.